Biosyntech Inc. Signs Scientific Collaboration Agreement With Nicholas Piramal India Limited

LAVAL, QUEBEC -- (MARKET WIRE) -- November 20, 2006 -- BioSyntech, Inc.(TSX: BSY) ("BioSyntech" or the "Company") is pleased to announce the signing of a scientific collaboration between the Company and their biopharmaceutical partner Nicholas Piramal. This collaboration will involve clinical studies for BST-InPod, which is being developed to alleviate the chronic pain associated with foot fat pads. This collaboration will help to generate more clinical data at a lower cost in India.